Tumor response and toxicities in cervical cancer patients with a different brachytherapy schedule (where a radioisotope will be kept inside the vaginal cavity to provide internal radiation near the tumor) involving 5 sessions of 6 radiation units each in two applications of a catheter.
Phase 2
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/06/068635
- Lead Sponsor
- Dr Muhammed Basil Y P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Biopsy-proven newly diagnosed carcinoma cervix
Patients fit for chemotherapy
Age less than 65 years without comorbid conditions
FIGO Stage IB, IIA, IIB, IIIB without lower one-third involvement
ECOG 0-2
No major life-threatening complications
Exclusion Criteria
More than 65 years
ECOG 3 or more
Prior pelvic radiotherapy
Uncontrolled Diabetes and hypertension
Patients with a prior history of DVT/Pulmonary embolism
Lower one-third involvement of any stage
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method